Non-invasive Evaluation of Portal Pressure by MRI

Noninvasive Diagnostic Platform for Liver Fibrosis and Portal Hypertension

NCT03277651 ·Status: UNKNOWN

LSM and SSM for the Diagnosis of CSPH: a Prospective Cohort Study

NCT06181409 ·Status: RECRUITING

Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non Alcoholic Fatty Liver Disease

NCT03245606 ·Status: COMPLETED

Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease

NCT02060565 ·Status: RECRUITING

PET / MR With PSMA for Diagnosis and Staging of Hepatocellular Carcinoma

NCT05580835 ·Status: UNKNOWN ·Phase: NA

3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension

NCT05475015 ·Status: RECRUITING

Myocardial Fibrosis and Inflammation in Liver Cirrhosis

NCT05047029 ·Status: COMPLETED

Performance of Imaging for the Diagnosis of Small Hepatocellular Carcinoma (< 3 cm)on Cirrhosis

NCT00848952 ·Status: UNKNOWN ·Phase: NA

Methods to Detect Liver Fibrosis

NCT03027700 ·Status: TERMINATED ·Phase: NA

Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis

NCT03142698 ·Status: UNKNOWN ·Phase: NA

Quantification of Hepatic Fibrosis by IVIM Sequences in 1.5T MRI

NCT03173287 ·Status: UNKNOWN ·Phase: NA

Agreement Among Expert Radiologists in Diagnosing Primary Liver Tumors by Magnetic Resonance Imaging (MRI)

NCT01234701 ·Status: COMPLETED

A Prospective Study of ¹⁸F-DFA PET Imaging for the Assessment of Liver Injury

NCT07050550 ·Status: RECRUITING

Liver Perfusion MRI With Quantification of Tumoral Perfusion for Early Assessment of the Response of Antiangiogenics Treatments in Hepatocellular Carcinoma

NCT02585687 ·Status: TERMINATED ·Phase: NA

Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of CSPH in Patients With cACLD

NCT06147947 ·Status: RECRUITING

A Novel Imaging Based Quantitative Model-aided Detection of Portal Hypertension in Patients With Cirrhosis (CHESS2104)

NCT05068492 ·Status: NOT_YET_RECRUITING

A Multicenter Prospective Study of Application of Platelet Mapping in Acute-on-chronic-liver Failure in China

NCT04119973 ·Status: COMPLETED

Value of MRCP+ And Liver Multiscan in the Management of Dominant Strictures in Primary Sclerosing Cholangitis

NCT05359497 ·Status: UNKNOWN ·Phase: NA

Functional MRI to Determine Severity of Cirrhosis

NCT03623360 ·Status: UNKNOWN

Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment

NCT01492127 ·Status: UNKNOWN ·Phase: NA

Two-dimensional Shear Wave Elastography for Assessment of Cirrhosis and Portal Hypertension

NCT06358092 ·Status: NOT_YET_RECRUITING

Development of Novel MRI Methods for Detecting, Discriminating, and Measuring Liver Fibrosis and Congestion in Fontan Patients

NCT03539757 ·Status: TERMINATED

Exploratory Study of MRI Biomarkers of NASH

NCT06626074 ·Status: RECRUITING ·Phase: NA

2D-shear Wave Spleen Elastography in Clinically Significant Portal Hypertension and High-risk Varices

NCT07122622 ·Status: RECRUITING

The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/Contrast-enhanced MRI in Malignant Liver Lesions

NCT07055048 ·Status: NOT_YET_RECRUITING